RxDoctor Payments Data

Rishin Patel, MD

Family Medicine · New Franklin, OHNPI 1730434291

Payments from drug & device makers

$660in general payments, 2019–2025

Across 28 payments — averaging $23.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$155
  • AbbVie$106
  • Dexcom, Inc.$80
  • Lilly USA, LLC$74
  • Abbott$46
  • Bayer$45
  • plus $154 from 8 others

What the payments were for

  • Food & beverage$64097%
  • Education$203%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$660 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$36,590
Medicare patients
143
Services billed
420

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin88$83,646
EliquisApixaban67$74,379
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$45,072
TrulicityDulaglutide19$32,514
XareltoRivaroxaban32$26,713
OzempicSemaglutide12$18,565
JanuviaSitagliptin Phosphate18$15,528
FarxigaDapagliflozin Propanediol12$12,104
Spiriva RespimatTiotropium Bromide12$10,854
Breo ElliptaFluticasone/Vilanterol20$10,450
Atorvastatin Calcium579$5,372
SymbicortBudesonide/Formoterol Fumarate17$4,854
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$4,430
Albuterol Sulfate HfaAlbuterol Sulfate98$3,422
Pantoprazole Sodium169$2,847

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$22$74,37967 claims
GSKTrelegy Ellipta, Breo Ellipta$155$55,52261 claims
Lilly USA, LLCTrulicity$74$32,51419 claims
Johnson & JohnsonXarelto$17$26,71332 claims
Novo NordiskOzempic$12$18,56512 claims
AstraZenecaFarxiga, Symbicort$15$16,95729 claims
MerckJanuvia$16$15,52818 claims
AbbVieSynthroid$106$85817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in New Franklin

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →